Low-Level Laser Therapy for Prevention of Oral Mucositis

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Mucositis
Interventions
DEVICE

Low Level Laser Therapy

Patients will receive LLLT three times per week concurrently with chemoradiotherapy. LLLT may be delivered either immediately prior to or after the patient's daily fraction of radiotherapy. Patients will be treated extra-orally with a THOR® LED cluster for one minute along the buccal mucosa on each side and intraorally for one minute to the tongue and soft palate. During each LLLT treatment session a thorough oral exam will be performed to identify any areas of mucositis. If the patient should develop intraoral lesions they will be targeted directly with the intraoral probe for one minute to each site of mucositis. The laser settings to be used are as follows: frequency 2.5 Hz; wavelength 660 nm; and power 75 mW, for an energy of 4.5 J.

Trial Locations (1)

15232

UPMC Shadyside Department of Radiation Oncology, Pittsburgh

All Listed Sponsors
lead

David A. Clump, MD, PhD

OTHER

NCT02682992 - Low-Level Laser Therapy for Prevention of Oral Mucositis | Biotech Hunter | Biotech Hunter